Comparison of three 18F-labeled 2-nitroimidazoles for imaging hypoxia in breast cancer xenografts: [18F]FBNA, [18F]FAZA and [18F]FMISO

article
Autores

Dos Santos, Sofia Nascimento

Wuest, Melinda

Jans, Hans-Sonke

Woodfield, Jenilee

Nario, Arian Pérez

Krys, Daniel

Dufour, Jennifer

Glubrecht, Darryl

Bergman, Cody

Bernardes, Emerson Soares

Wuest, Frank

Data de Publicação

1 de setembro de 2023

Resumo

Resumo não disponível.

Citação

BibTeX
@online{santos,_sofia_nascimento2023,
  author = {Santos, Sofia Nascimento, Dos and Melinda , Wuest and
    Hans-Sonke , Jans and Jenilee , Woodfield and Arian Pérez , Nario
    and Daniel , Krys and Jennifer , Dufour and Darryl , Glubrecht and
    Cody , Bergman and Emerson Soares , Bernardes and Frank , Wuest},
  title = {Comparison of three 18F-labeled 2-nitroimidazoles for imaging
    hypoxia in breast cancer xenografts: {[}18F{]}FBNA, {[}18F{]}FAZA
    and {[}18F{]}FMISO},
  volume = {124-125},
  date = {2023-09-01},
  doi = {10.1016/j.nucmedbio.2023.108383},
  langid = {pt-BR},
  abstract = {Resumo não disponível.}
}
Por favor, cite este trabalho como:
Santos, Sofia Nascimento, Dos, Wuest Melinda, Jans Hans-Sonke, Woodfield Jenilee, Nario Arian Pérez, Krys Daniel, Dufour Jennifer, et al. 2023. “Comparison of three 18F-labeled 2-nitroimidazoles for imaging hypoxia in breast cancer xenografts: [18F]FBNA, [18F]FAZA and [18F]FMISO.” Nuclear Medicine and Biology. September 1, 2023. https://doi.org/10.1016/j.nucmedbio.2023.108383.